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Abstract.We investigated the role of the Q291 glutamine
residue in the functioning of the rat g-aminobutyric acid
(GABA) transporter GAT-1. Q291 mutants cannot trans-
port GABA or give rise to transient, leak and transport-
coupled currents even though they are targeted to the
plasma membrane. Coexpression experiments of wild-
type and Q291 mutants suggest that GAT-1 is a functional
monomer though it requires oligomeric assembly for
membrane insertion. We determined the accessibility of
Q291 by investigating the impact of impermeant sulfhyd-
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ryl reagents on cysteine residues engineered in close
proximity to Q291. The effect of these reagents indicates
that Q291 faces the external aqueous milieu. The intro-
duction of a steric hindrance close to Q291 by means
of [2-(trimethylammonium)ethyl] methanethiosulfonate
bromide modification of C74A/T290C altered the affin-
ity of the mutant for cations. Taken together, these results
suggest that this irreplaceable residue is involved in the
interaction with sodium or in maintaining the cation ac-
cessibility to the transporter.
Key words. Neurotransmitter transporter; GAT-1; electrophysiology; site-directed mutagenesis; Xenopus laevis oocyte;
structure-function relationship.
g-Aminobutyric acid (GABA) is the major inhibitory
neurotransmitter in mammalian brain, and the GABA
transporter GAT-1 is an integral membrane protein re-
sponsible for the reuptake of GABA from the synaptic
cleft during neurotransmission. GAT-1 was the first
cloned member of a large family of homologous proteins,
the Na+/Cl–-dependent neurotransmitter transporters [1],
which includes transporters for other neurotransmitters
such as norepinephrine, dopamine, serotonin and glycine,
as well as for a number of other substrates that share the
common property of being amino acids or amino acid
derivatives [2]. These membrane proteins are predicted
to have 12 transmembrane-spanning domains (TMDs)
linked by hydrophilic loops with the NH2 and COOH ter-
minals inside the cell, a topological model that has been
confirmed for the serotonin transporter by means of site-
directed chemical labeling [3]. GAT-1 mediates the elec-
trogenic reuptake of GABA in the presence of sodium
and chloride ions by means of a mechanism that has been
extensively studied [4–12].
Many attempts have been made to determine which of the
transporter amino acid residues are involved in the inter-
action with GABA and with Na+ and Cl– ions, and which
participate in the conformational changes associated with
translocation [13–15]. As GABA is a zwitterionic mole-
cule and its cosubstrates are charged species, the first
studies focused on the charged and conserved residues
predicted to be located in (or adjacent to) the transmem-
brane (TM) domains. This allowed the identification of * Corresponding author.
Cellular and Molecular Life Sciences
Research Article
Role of the conserved glutamine 291 in the rat 
g-aminobutyric acid transporter rGAT-1
S.A. Maria,A. Soragnab , M. Castagnaa, M. Santacrocea,C .P e r e g o a, E. Bossib,A.Peresb and V. F. Sacchia, *
a Institute of General Physiology and Biological Chemistry ‘G. Esposito’, University of Milan, Via Trentacoste 2,
20134 Milano (Italy), Fax: +390250315775, e-mail: franca.sacchi@unimi.it
b Laboratory of Cellular and Molecular Physiology, Department of Structural and Functional Biology and Center for
Neuroscience, University of Insubria, 21100 Varese (Italy)
Received 24 October 2005; accepted 11 November 2005
Online First 27 December 2005two charged residues that are critical for GAT-1: arginine
69 [16] and glutamate 101 [17]. A different approach in-
vestigated the possible role of aromatic residues through
the interaction of their p electrons with positively charged
substrates such as Na+ or the amino group of the neuro-
transmitter [18–20]. A number of tryptophan residues re-
siding within the membrane domain of the GABA trans-
porter have been investigated [21]. Tryptophan 68 was ini-
tially believed to interact with the amino group of the
neurotransmitter, but a subsequent and more detailed
analysis revealed its involvement in cation binding [22].
Cysteines introduced at positions 68 (TMD 1) and 143
(TMD 3) have recently been shown to be in close proxim-
ity within the transporter monomer, thus supporting the
idea that the binding determinants for the substrate in
GAT-1 are located in TMD 1 and 3 [23]. Analysis of the ty-
rosine residues of GAT-1, predicted to be located in the
membrane, and conserved throughout the family, has
shown that tyrosine 140 is critical for neurotransmitter
recognition [24].
We investigated the role in GAT-1 function of glutamine
291 which, according to secondary-structure prediction
algorithms, is located at the extracellular membrane sur-
face. Despite their rare presence in TM helices, polar
residues are often highly conserved in multispanning TM
proteins [25], which suggests that they provide function-
ally and/or structurally required molecular interactions,
and that evolutionary pressure prevents their substitution
in related proteins in different organisms. Q291 is strictly
conserved in all members of the family including bacter-
ial and archaeal proteins, indicating that it may play a fun-
damental role in the function of these transporters. 
Our experiments confirmed the topological prediction of
Q291 on the extracellular membrane surface and its cru-
cial role in GAT-1 function. Q291 mutants, although in-
serted into the plasma membrane, are unable to transport
measurable amounts of GABA or to elicit any of the cur-
rents shown by the wild-type (WT) transporter. A defect
in the recognition of the organic substrate cannot explain
all the experimental data and a defect in quaternary pro-
tein folding cannot be envisaged. Our hypothesis is that
Q291 may play a fundamental role in the initial interac-
tion of the transporter with sodium, which would obvi-
ously involve other critical residues at the protein mem-
brane surface. Our data do not necessarily indicate a di-
rect role for Q291 in cation binding, but Q291 may be
fundamental to maintain the conformational integrity of
an external region of the transporter that makes it acces-
sible to the cation. Very recently, the first structure of a
member of the Na+/Cl–-dependent neurotransmitter trans-
porter family was solved. Yamashita et al. [26] reported
the crystal structure of the leucine transporter LeuTAa
from the bacterium Aquifex aeolicus. This structure rep-
resents a conformation of the transporter in which the
binding pocket is occluded and the external and internal
gates are closed. The molecular interactions of LeuTAa
Q250, which corresponds to GAT Q291 (fig. 1A), are
clearly shown and compatible with our data concerning
the role of Q291 in GAT function. 
Materials and methods
Site-directed mutagenesis.The oocyte expression vector
pAMV-PA containing rGAT-1 cDNA was a generous gift
from H. A. Lester and C. Labarca (Division of Biology,
California Institute of Technology, Pasadena, Calif.). The
mutants were synthesized by PCR using the Quick
Change Site-Directed Mutagenesis Kit (Stratagene), and
the mutations were confirmed by DNA sequencing.
Oocyte expression of WT and mutated transporters.
The oocyte expression vector pAMV-PA containing WT
or mutant GAT-1 cDNA was NotI digested, in vitro
capped, and transcribed using T7 RNA polymerase (Stra-
tagene). The oocytes were collected as previously de-
scribed [27], and injected with 12.5 ng cRNA in 50 nl of
water using a manual microinjection system (Drum-
mond). The oocytes were incubated at 18 °C for 3–4 days
in Barth’s solution supplemented with 50 mg/ml gentam-
icin and 2.5 mM sodium pyruvate before the experi-
ments.
Transport experiments. GABA uptake was measured 3
days after injection. Groups of 10–12 oocytes were incu-
bated in 100 ml uptake solution (100 mM NaCl, 2 mM
KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM HEPES/Tris, pH
7.5) with 100 mM [3H]GABA (1000 KBq/ml) for 60 min.
The oocytes were then rinsed with ice-cold wash solution
(100 mM choline chloride, 2 mM KCl, 1 mM CaCl2,
1mM MgCl2, 10 mM HEPES/Tris, pH 7.5) and dissolved
in 250 ml of 10% SDS for liquid scintillation counting.
GAT-1-mediated transport was plotted as the difference
between the mean uptake measured in cRNA-injected
oocytes and that observed in non-injected oocytes.
Inhibition studies with sulfhydryl reagents. Before
the uptake experiments and unless otherwise indicated,
the oocytes were incubated at room temperature with
2 mM of the cysteine-modifying reagents MTSET and
sodium (2-sulfonatoethyl) methanethiosulfonate [a-(tri-
methylammonium)ethyl]methanethiosulfonate bromide
(MTSES) for 15 min in Barth’s solution, subsequently
rinsed with the wash solution, and then incubated for
uptake measurements. In electrophysiological experi-
ments, the same oocytes were tested before sulfhydryl
modification and then again after methanethiosulfonate
(MTS) incubation (under the same conditions as used in
the uptake studies). In this way, each oocyte was its own
control.
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experiments were performed using GeneClamp (Axon
Instruments), or Oocyte Clamp OC-725B (Warner In-
struments) amplifiers. Reference electrodes were con-
nected to the experimental oocyte chamber via agar
bridges (3% agar in 3 M KCl) to minimize the effects of
chloride on junction potential. Borosilicate electrodes
with a tip resistance of 0.5–2 MW were filled with 3 M
KCl. The holding potential was kept at –40 mV , and 400-
ms voltage pulses were applied in the voltage range –140
mV to 40 mV in 20-mV increments. Four pulses were av-
eraged at each potential; signals were filtered at 1 KHz
and sampled at 2 KHz. The experimental protocols, data
acquisition and analysis were performed using pClamp
software (Axon Instruments), and all of the figures were
prepared using Origin 5.0 software (Microcal Software).
The external solution consisted of (in mM): NaCl98,
LiCl98, TMACl (tetramethylammonium chloride) or
NMDG (N-methyl-D-glucamine) 98, MgCl2 1, CaCl2
1.8, HEPES 5; pH was adjusted to a final value of 7.6 by
adding NaOH, LiOH, TMAOH or HCl. In the experi-
ments using reduced sodium concentrations, the cation
was iso-osmotically replaced by TMA+ or NMDG. To in-
duce transport-associated currents, GABA was added at a
final concentration of 100 µM, unless otherwise stated.
The transport-associated currents were estimated by sub-
tracting the traces in the absence of GABA from those in
its presence under each experimental condition. The ex-
periments investigating the sodium-induced inhibition of
lithium currents were performed using 96 mM lithium in
the presence of 2 mM sodium. To maintain osmolarity in
the control solution, 2 mM NMDG were added to 96 mM
lithium. To isolate the pre-steady-state currents, the spe-
cific rGAT-1 blocker, 1-(4,4-diphenyl-3-butenyl)-3-pi-
peridine carboxylic acid hydrochloride (SKF89976A)
(Tocris), was used at a final concentration of 30 µM. All
of the experiments were performed at room temperature.
Cell surface biotinylation. The cell surface expression
of GAT-1 and the mutants was tested using a membrane-
impermeant reagent, EZ-Link Sulfo-NHS-SS-Biotin
(Pierce). Groups of five to ten oocytes were rinsed three
times with ice-cold PBS, pH 8, and then incubated twice
on ice in 750 µl PBS containing EZ-Link Sulfo-NHS-SS-
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Figure 1. Sequence conservation of the region including TMD 6 within different Na+/Cl–-dependent neurotransmitter transporters, topo-
logical prediction of Q291 and representation of the GAT-1 TM helix 6. (A) The first row shows amino acid residues 284–313 according
to rGAT-1 numbering, and the last acid residues 243–270 according to A. aeolicus LeuTAa numbering (see Discussion for further details).
Sequence similarity with GAT-1 of the homologues from archaeal, bacterial and mammalian sources is shown. The arrows indicate the
residues mutated in this study. Q291 is indicated in bold. (B) Assignment of Q291 to the C termini of the third extracellular loop or the N
termini of TMD 6 according to different secondary-structure prediction algorithms. (C) The secondary structure prediction system for
membrane proteins SOSUI [39] assigns the sequence of 23 amino acids ATQIFFSYGLGLGSLIALGSYNS from 289 to 311 of GAT-1 to
TMD 6. The residues mutated in this study are shown in black circles.Biotin (1.3 mg/ml) for 15 min. After labeling, the oocytes
were rinsed with ice-cold PBS, incubated in 50 mM
glycine in PBS for 15 min on ice in order to quench the
unreacted biotinylation reagent, and then dissolved in ly-
sis buffer (in mM: NaCl 150, Tris/HCl 20, pH 7.6, 1%
Triton X-100, EDTA 5) supplemented with 10 ml/ml of
the protease inhibitors leupeptin and aprotinin by means
of gentle shaking on ice for 40 min. The solubilized
oocytes were centrifuged for 15 min at 13,000 g, and the
biotinylated proteins were recovered from the super-
natant solution by adding 50 µl ImmunoPure Immobi-
lised Streptavidin beads (Pierce), and incubating for 1.5 h
with gentle agitation on ice. The beads were then washed
twice with lysis buffer and once with 50 mM TrisHCl, pH
7.5. The final pellets were resuspended in the appropriate
SDS sample buffer and incubated for 2 min at 100 °C be-
fore being loaded onto an 8–10% polyacrylamide gel for
SDS/PAGE. Total samples were obtained by heating 1/10
of the lysates in SDS sample buffer at 100 °C for 2 min,
followed by SDS-PAGE. After SDS-PAGE, the proteins
were transferred to nitrocellulose and GAT-1 was de-
tected by means of ECL (Amersham) using an affinity-
purified antibody to the COOH-terminal tail of GAT-1 at
a 1:1500 dilution and horseradish peroxidase-conjugated
secondary antibody at a 1:10,000 dilution. All of the an-
tibody, blocking and washing solutions contained 5%
milk to minimize the appearance of non-specific bands.
The cell surface expression of GAT Q291 mutants was
quantified by means of densitometric analysis using
Scion Image software.
Results
Analysis of Q291 mutants. A sequence-alignment ana-
lysis of about 250 proteins belonging to the family of Na+/
Cl–-dependent neurotransmitter transporters (ranging
from prokaryotes to human proteins) identified the most
conserved residues of the family (see fig. 1 for an extract
of this analysis). One of the three most conserved
residues was Q291 (GAT-1 numbering), as 97.5% of the
sequences have a glutamine residue in the corresponding
position. According to secondary-structure prediction al-
gorithms, GAT-1 Q291 is located on the NH2-terminal
side of the sixth TM domain or on the COOH-terminal
portion of the third extracellular loop (fig. 1B).
To investigate the role of glutamine 291 in GAT-1 func-
tion, we used site-directed mutagenesis to delete the
residue or replace it with different amino acids. The mu-
tant proteins were expressed in Xenopus laevis oocytes
and compared with the WT transporter. The deletion of
Q291 or its substitution by the amino acids leucine, as-
paragine or glutamate caused a complete loss of function.
None of the mutants was capable of transporting GABA
(fig. 2A), and electrophysiological measurements showed
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Figure 2. Transport activity and cell surface expression of WT GAT-
1 and Q291 mutants. (A) Sodium-dependent 100 mM [3H]GABA
uptake in Xenopus oocytes expressing WT GAT-1 and the mutants
Q291L, D291, Q291N and Q291E. The uptake value is expressed as
the percentage of transport activity of WT GAT-1. Mean values ±
SE of 10–12 oocytes in at least three independent experiments. (B)
Surface biotinylation of Xenopus oocytes expressing WT and mu-
tated proteins. The GAT-1- and mutant-expressing oocytes were
treated as described in Materials and methods. The image shows the
biotinylated and total samples of WT, Q291L, D291, Q291N,
Q291E and uninjected oocytes. The positions of standard molecu-
lar mass are indicated on the left. (C) Cell surface expression of
GAT-1 Q291 mutants quantified by densitometry. The data are ex-
pressed as the % of WT GAT-1 surface expression; mean values +
SE of at least three different experiments.that they were unable to generate transport-coupled cur-
rents (fig. 3A), pre-steady-state currents (fig. 3C) or lith-
ium leak currents (data not shown). 
As the complete absence of transport activity and of the
currents characterizing the WT transporter may have
been due to inefficient targeting to the plasma membrane,
the cell surface expression of the mutants was tested
using a membrane-impermeant biotinylation reagent,
EZ-Link Sulfo-NHS-SS-Biotin. Figure 2B shows the
amounts of biotinylated and total WT GAT-1 and mutant
proteins (Q291L, D291, Q291N and Q291E). As previ-
ously reported, WT GAT-1 [28] and the mutants were rep-
resented by a ª60-kDa band and an upper band compati-
ble with a dimeric aggregate of the transporter. The speci-
ficity of the antibody is shown by the lack of labeling in
the control lanes, which represent samples prepared from
uninjected oocytes. All of the mutant proteins reached the
plasma membrane, which indicates that the deletion or
substitution of Q291 did not impair GAT-1 cell surface
targeting and thus ruled out the hypothesis of defective
targeting as the cause of their lack of activity.
Coexpression experiments. Transport proteins are fre-
quently oligomers [29], but the significance of the protein
quaternary structure in transport activity has been eluci-
dated in only a few cases. With the exception of glycine
transporters [30], most neurotransmitter transporters form
constitutive oligomers. GAT-1 oligomers have been visu-
alized in living cells by means of fluorescence resonance
energy transfer (FRET) microscopy [31], and some inter-
action motifs have been shown to support the association
of TM domains in GAT-1 and related transporters [32–36].
The characteristics of the Q291 mutants made them good
candidates for coexpression experiments designed to in-
vestigate the role of GAT-1 oligomerization, because they
are non-functional but expressed at the cell surface and
also capable of quaternary assembly (fig. 2B). The in-
volvement of Q291 in oligomerization can also be ex-
cluded by evidence that the export of GAT-1 and other
members of the family to the plasma membrane is depen-
dent on oligomerization (see Discussion). 
If the transporter functions only as an oligomer, the coex-
pression of WT and a correctly inserted non-functional
mutant should impair the transport activity of the WT.
The coinjection of equal, non-saturating amounts of WT
and mutant GAT-1 cRNAs did not have any appreciable
effect on WT-mediated GABA transport (fig. 4), even af-
ter the coinjection of the WT and mutant in a 1:2 ratio
which could possibly favor the effect of the mutant on the
WT (data not shown). This was observed after the coex-
pression of WT GAT-1 with the mutants Q291L, D291,
Q291N and Q291E, as well as with the mutant Y140F
which is known to be expressed at the cell surface but is
non-functional [24]. As these mutants are not retained in-
tracellularly and are capable of quaternary assembly, their
coexpression with the WT should produce a mixture of
oligomers consisting of pure WT, pure mutated, and het-
eromeric oligomers. The absence of any effect of mutant
coexpression on WT transport activity indicates that a
pure WT oligomer is not required for sodium-coupled
GABA transport; in other words, although it requires
oligomeric assembly for efficient surface targeting, GAT-
1 seems to be a functional monomer.
Accessibility studies. In an attempt to elucidate the role
of Q291 further, we studied its accessibility by testing the
impact of impermeant sulfhydryl-modifying reagents on
engineered cysteine residues. This was done using the
C74A mutant because this residue is the only external
cysteine of GAT-1 affected by impermeant MTS reagents
[14, 37, 38]. As the C74A/Q291C mutant is devoid of
transport activity (fig. 5), as well as transient, leak and
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Figure 3. Electrophysiological characterization of WT and mutated GAT-1. (A) Current vs voltage relationships of the transport-associated
current elicited by 100 mM GABA in WT GAT-1 (squares), and the mutants Q291E (downward-pointing triangles), Q291L (upward-point-
ing triangles), Q291N (circles) and D291 (diamonds). None of these mutants gave rise to a transport-associated current. Mean values ± SE
from eight to ten oocytes from three different batches. (B, C) Sample traces showing pre-steady-state currents for WT GAT-1 (B) and the
indicated mutants (X stands for E, L and N in C). None of the mutated forms showed pre-steady-state currents. The traces were obtained
as explained in Materials and methods. Only the steps from –120 mV to +40 mV are shown (in 40-mV increments).transport-associated currents (data not shown), we could
not perform any functional test to monitor the effect of
impermeant MTS reagents on it. Furthermore, the acces-
sibility of the cysteine introduced into the C74A/Q291C
mutant could not be determined using the cysteine-spe-
cific biotinylation reagent MTSEA-biotin (N-biotiny-
laminoethylmethanethiosulfonate) as WT GAT-1 and also
the C74A/C399A mutant, lacking the main targets of
both permeant and impermeant MTS reagents [13], are
labeled by MTSEA-biotin. This result indicates that this
reagent can modify other endogenous cysteines [38]. 
We therefore could not obtain any direct data concerning
the external aqueous accessibility of Q291, although the
presence of a highly hydrophilic residue such as gluta-
mine in this position suggests that it should have aqueous
accessibility. In an attempt to overcome this obstacle, we
tested the external aqueous accessibility of the region in
which Q291 is located by inserting cysteine residues in
proximity to Q291 on the C74A background to produce
the double mutants C74A/T290C, C74A/I292C, C74A/
F294C, C74A/S295C, C74A/L298C and C74A/S302C
(figs. 1A, C). The cysteines F294C, S295C, L298C and
S302C were inserted downstream of Q291 and, according
to the SOSUI secondary-structure prediction algorithm,
are predicted to face the same side of a putative a-helix
of TMD 6 just below Q291 [39] (fig. 1C). Transport ac-
tivity could be measured in two of the six double mutants,
C74A/T290C and C74A/S295C (fig. 5), which showed
reduced uptake and smaller transport-coupled currents
(data not shown) in comparison with the WT form. Pre-
incubation with the positively charged MTSET (2 mM
for 15 min) caused an 80% inhibition of uptake in C74A/
T290C, and 90% in C74A/S295C (fig. 6, hatched bars);
similar inhibition was also observed after 10 min pre-in-
cubation with 150 mM MTSET (data not shown). Under
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Figure 4. Coexpression of WT GAT-1 and mutants Q291L, D291,
Q291N, Q291E and Y140F. [3H]GABA uptake at a concentration of
100 mM mediated by WT and the indicated WT/mutant pairs. From
left to right, the oocytes were injected with 12.5 ng of WT cRNA
(concentration 0.250 mg/ml), 1 ng of WT cRNA (concentration 0.02
mg/ml) and 1 ng WT cRNA mixed with 1 ng of the indicated mu-
tated cRNAs (ratio 1:1). The uptake values are expressed as the per-
centage of transport activity measured in the oocytes injected with
1 ng WT GAT-1 cRNA (concentration 0.02 mg/ml). Mean values ±
SE of groups of 10–12 oocytes in at least three independent exper-
iments. Insert: relationship between 100 mM [3H]GABA uptake and
the concentrations of the injected WT GAT-1 cRNA (0.02 mg/ml,
grey circle; 0.04 mg/ml, white circle) corresponding to 1 and 2 ng.
Mean values ± SE of groups of 10–12 oocytes.
Figure 5. GABA transport mediated by cysteine mutants. [3H]GABA
uptake at a concentration of 100 mM as mediated by the C74A, C74A/
T290C, C74A/Q291C, C74A/I292C, C74A/F294C C74A/S295C,
C74A/L298C and C74A/S302C mutants, expressed as the percent-
age of transport activity shown by WT GAT-1. Mean values ± SE of
10–12 oocytes in at least three independent experiments. *, signifi-
cantly different from non-injected oocytes (Student’s t test, p < 0.05).
Figure 6. MTSET effect on [3H]GABA uptake induced by GAT-1
C74A, C74A/T290C and C74A/S295C mutants. 100 mM [3H]GABA
uptake expressed as the percentage of C74A mediated by the indi-
cated mutants. The white bars represent control conditions (oocytes
untreated with the modifying reagent), and the hatched bars, the
transport activity after 15 min incubation with MTSET at a con-
centration of 2 mM. Mean values ± SE of 10–12 oocytes in at least
three independent experiments.both conditions, the Na+ and GABA substrates did not af-
fect MTSET sensitivity (data not shown). The negatively
charged MTSES (2 mM pre-incubation for 15 min),
whose size is similar to that of MTSET, had the same ef-
fect (data not shown). 
The inhibition of these mutants (which respectively ex-
pose a cysteine residue just before and one helix turn be-
low Q291) by impermeant MTS reagents suggests that
the hydrophilic Q291 is accessible from the external
aqueous milieu. One possible explanation for this inhibi-
tion is that the C74A/T290C and C74A/S295C mutants
may expose an endogenous and previously inaccessible
cysteine residue that can interact with the modifying
reagents. Unfortunately, the introduction of a serine or
alanine residue in these positions completely deprived the
mutants C74A/T290S and C74A/S295A of transport ac-
tivity (data not shown), thus preventing us from testing
whether their mutations expose endogenous cysteine
residues. 
To determine whether the reduced or completely absent
transport activity of the cysteine mutants is due to an ef-
fect on function or defective targeting, their surface ex-
pression was tested by biotinylation. All of the mutants
were correctly expressed on the cell surface with the ex-
ception of C74A/I292C, which showed reduced mem-
brane expression (data not shown). The reduced or absent
activity of the mutants, therefore, apparently cannot be
ascribed to deficient plasma membrane expression, thus
highlighting the importance of this region in the function
of the transporter.
Effect of sulfhydryl modification on the biophysical
properties of the double C74A/T290C mutant. Fig-
ure 7A shows the ability of this double mutant to give rise
to transport-associated currents under control conditions:
i.e. when 100 mM GABA was perfused before MTSET
incubation. After treatment with the impermeant cys-
teine-modifying reagent, we did not observe a GABA-in-
duced current but we did find a larger sodium leakage
current at –40 mV membrane potential (fig. 7B), thus in-
dicating a change in Na+-transporter interaction. Statisti-
cal analysis showed a significant difference (fig. 7C) in
the sodium leakage current before and after incubation
with MTSET. 
To clarify these effects further, we undertook a more de-
tailed analysis by testing the behavior of transport-associ-
ated, transient and lithium leak currents under a wider
range of voltages (figs. 8, 9). The C74A/T290C mutant
showed WT-like behavior in terms of GABA apparent
affinity (figs. 8A, 8B): by plotting the calculated concen-
tration of GABA giving rise to half the maximal current
(K1/2 (GABA)) at each potential versus the membrane poten-
tial (fig. 8B), we obtained a curve resembling that of the
WT in terms of both voltage dependence and absolute
values (i.e. about 10 mM at –40 mV) [see refs. 9, 40]. In-
cubation with MTSET abolished the transport-associated
current at all voltages and GABA concentrations up to 3
mM (fig. 8A, filled symbols). Obviously, in this latter
case, the apparent affinity for GABA could not be deter-
mined.
We also looked at the transient pre-steady-state currents
in the C74A/T290C mutant before and after MTSET
treatment (fig. 8C, D). A detailed analysis of these cur-
rents in a control solution containing 98 mM sodium con-
firmed WT-like behavior: fitting the sigmoid Q/V curve
(empty squares in fig. 8E) with a Boltzmann function
gave a V1/2 value of –27 ± 2 mV (n=8), similar to the WT
value in the same batch (–26 ± 1 mV , n=3, not shown).
The analysis of the charge equilibration rate (empty
squares in fig. 8F) also confirmed that the mutation did
not alter the biophysical parameters of the transporter.
MTSET treatment greatly impaired C74A/T290C tran-
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Figure 7. Effect of MTSET on transport-associated and sodium leakage currents of the C74A/T290C double mutant. (A, B) Sample traces
of transport-associated and sodium leakage currents recorded at –40 mV in an oocyte expressing the C74A/T290C mutant before (A) and
after (B) incubation with MTSET. GABA was added at the time indicated by the black bars. The dashed lines represent zero current level,
and the arrows indicate the sodium leakage current. (C) Evaluation of sodium leakage current under control conditions and after MTSET
treatment (n=8) recorded at –40 mV: the values are significantly different (*Student’s t test, p < 0.05).sient currents, which could only be seen at depolarized
potentials (fig. 8D). The results of the integration of these
transients (plotted as filled squares in fig. 8E) have been
arbitrarily shifted along the ordinate axis to match the
charge value before MTSET treatment at negative poten-
tial. Although this Q/V curve is clearly far from reaching
saturation at positive potential, there was a significant
rightward shift of the sigmoid, with an estimated V1/2
value of +27 ± 8 mV (filled squares in fig. 8E), and the
alteration can also be seen in the rate of decay (filled
squares in fig. 8F). This effect may be related to the in-
creased Na+ leak current shown in figure 7. Furthermore,
a shift of the Q/V curve toward more positive potentials
may be interpreted as an increase in sodium affinity [41]. 
To examine further whether MTSET incubation alters the
interaction of the transporter with cations, we considered
the lithium leak current. Like many other cotransporters
of this family, GAT-1 also has uncoupled or leakage cur-
rents (i.e. transmembrane currents in the absence of or-
ganic substrate) that are best seen in the presence of
lithium [22].
When lithium was perfused at a concentration of 98 mM,
the mutated C74A/T290C transporter showed the same
uncoupled current as the WT (not shown), thus confirm-
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Figure 8. Biophysical characterization of the C74A/T290C double
mutant. (A) Current vs voltage relationships of the transport-associ-
ated current elicited by the indicated GABA concentrations in GAT-
1 C74A/T290C in [Na+]o=98 mM before (empty symbols) and after
MTSET (filled symbols) treatment. Even at high GABA concen-
trations (underlined), no transport-associated current could be seen
after MTSET treatment. (B) GABA apparent affinity evaluated un-
der control conditions as the concentration giving rise to half Itr at
each potential, resembling WT-like behavior [9]. Mean values ± SE
of eight oocytes in both panels A and B. (C) and (D) Typical tran-
sient traces of the GAT-1 C74A/T290C double mutant before (C)
and after (D) MTSET treatment recorded in an external solution
containing 98 mM sodium. (E) Representative Q/V graph from the
integration of the transient currents shown in panels C and D before
(empty squares) and after (filled squares) MTSET treatment. Fit-
ting the sigmoid of the Q/V curve with a Boltzmann function gave
V1/2 values of –27 ± 2 mV before treatment and +27 ± 8 mV after
treatment (under control conditions, the V1/2 for the WT form in the
same batch was –26 ± 1 mV). The curves represent the mean values
± SE of the charge calculated from the integration of the ‘on’ and
‘off’transients. The MTSET curve was arbitrarily shifted to match
the control charge values at negative potentials. (F) Typical rate/V
graph of the transient currents shown in panels C and D before
(empty squares) and after (filled squares) MTSET treatment.
Figure 9. Lithium currents in the C74A and C74A/T290C mutants.
Current vs voltage relationships of the C74A (A) and C74A/T290C
(B) mutants before (squares) and after (circles) 15 min treatment
with 2 mM MTSET. The recordings were made from the same
oocytes and the current values were normalized at –140 mV before
treatment. Mean values ± SE of 10 oocytes from two different
donors. (C) Evaluation of lithium current (calculated as the differ-
ence between ILi+ and INa+) under control conditions and after MT-
SET treatment (n=8) measured at fixed membrane potential (–40
mV). (D) Evaluation of sodium-induced inhibition of lithium cur-
rent in the double mutant. Oocytes expressing the C74A/T290C
mutant were perfused with a solution containing 96 mM Li+, and
subsequently with a solution with 96 mM Li+ and 2 mM Na+ both
before and after 15 min incubation with 2 mM MTSET. The resid-
ual lithium current was estimated by normalizing the current in the
presence of 2 mM sodium to the value in its absence at –140 mV af-
ter subtraction in the presence of SKF89976A. The recordings were
made from the same oocytes (n=8, two batches). The data in C and
D were statistically analyzed using Student’s t test: *, significantly
different (p < 0.05); n.s., not significant.ing that the double mutations did not affect the function
of the transporter. After incubation with MTSET, there
was an increase in the lithium current at all tested poten-
tials (circles in fig. 9B); the fact that this was not seen in
the C74A mutant (fig. 9A) suggests that it is due to the
MTSET-induced modification of the cysteine introduced
in position 290. As shown in figure 9C, the increase in
lithium current measured at –40 mV membrane potential
was significantly different. The uncoupled lithium cur-
rent exhibited by WT GAT-1 has been shown to be non-
competitively inhibited by the presence of even small
amounts of sodium ions, with an IC50 of about 1.5 mM
[12, 14, 42]. As we have shown that cysteine-modifying
reagents alter the interaction of cations with the double-
mutated transporter by increasing both sodium and
lithium leakage currents, we further tested if sodium in-
hibition was altered by MTSET. The lithium currents
were recorded from C74A/T290C-expressing oocytes be-
fore and after 15 min treatment with 2 mM MTSET, in
both the absence and presence of 2 mM sodium. The
sodium concentration was chosen because, as it is above
the reported IC50, it reduces the lithium current to about
30% of the control condition [14]. The analysis was made
after subtracting the recording obtained in the presence of
SKF89976A in 96 mM Na+. For each experimental con-
dition, the current values (in both the absence and pres-
ence of sodium) were normalized with respect to the
value in control condition (96 mM Li+ and absence of
Na+) at –140 mV . Figure 9C shows that, under control
conditions, the presence of 2 mM Na+ blocks the lithium
leakage current to the same extent as in the WT. After
MTSET treatment, this inhibition was not abolished or
affected in any way, and the residual currents under the
two conditions were not significantly different. Further-
more, the blockade was not significantly different when
compared with the WT (data not shown). The introduc-
tion of bulk and charge by the MTSET-induced modifi-
cation of position 290 therefore significantly increases
the apparent affinity of the transporter for cations, but
does not modify the non-competitive inhibition of lithium
currents by sodium ions.
Discussion
To identify the critical residues of GAT-1, we made a de-
tailed analysis of about 250 amino acid sequences belong-
ing to the family of Na+/Cl–-dependent neurotransmitter
transporters, and found that one of the most conserved
amino acids was the glutamine residue GAT-1 Q291 (fig.
1A), which is predicted to be located on the extracellular
membrane surface (fig. 1B). All of our conservative and
non-conservative mutations of Q291 abolished the func-
tion of GAT-1, as they showed no GABA transport (fig. 2)
or any kind of current (fig. 3) even though they were
sorted to the plasma membrane (fig. 2B). As the substitu-
tion or deletion of Q291 did not impair the cell surface tar-
geting of GAT-1 in oocytes (fig. 2B) and cells (immuno-
fluorescence experiments, data not shown), we can rule
out defective targeting as the reason for the inactivity of
the Q291 mutants. Furthermore, the involvement of Q291
in oligomerization can be excluded, because GAT-1 re-
quires correct quaternary assembly for its efficient exit
from endoplasmic reticulum and subsequent delivery to
the plasma membrane [32, 34]. The fact that the Q291 mu-
tants were expressed on the cell surface indicates that they
form oligomers, and all of them showed the dimeric form
of the protein even under experimental denaturing condi-
tions (fig. 2B). Worth noting is that Hastrup et al. [33]
replaced cysteines in TMD 6 at positions 317–321 (cor-
responding to GAT 291–295) in a cysteine-depleted dop-
amine transporter (DAT) construct, and found that the re-
placement of DAT Q317, F320 and S321 with cysteine
was not tolerated because these constructs were not ex-
pressed at the cell surface (at least in the cysteine-depleted
DAT background).
Although Q291 does not seem to be involved in oligo-
merization, our results do not rule out the possibility that
it may promote the association of TM helices within the
same monomer. As it is a hydrogen bond donor and ac-
ceptor, glutamine may interact with the polar residues of
other TM helices and/or with substrates that could inter-
vene as alternative hydrogen-bonding partners in place of
other hydrophilic interactions [25].
With the exception of the glycine transporter (GLYT)
[30], neurotransmitter transporters (such as GAT, the sero-
tonin transporter SERT and DAT) exist in the membrane
as dimers [31, 33, 43], or dimers of dimers [35]. Moreover,
there is good evidence that the export of GAT-1 and other
members of the family to the plasma membrane depends
on oligomerization [32–34, 44, 45]. Mutant transporters
in the membrane that lack transport activity can be used to
investigate the functional role of the quaternary assembly
of the protein by means of a functional approach based on
coexpression experiments. Assuming that the assembly of
monomeric proteins is a random process, and that only
dimers of two WT monomers or tetramers of four WT
monomers are functional, the coexpression of WT and
correctly sorted non-functional mutants should affect WT
transport activity. However, the data in figure 4 show that
the coexpression of WT and correctly sorted non-func-
tional GAT-1 mutants did not have any effect on GABA
transport, thus suggesting that GAT-1 is fully functional as
a monomer. Similar results were obtained when mutant
expression was increased from 1:1 to 1:2. Sodium-cou-
pled GABA transport therefore does not seem to require
oligomerization [46], which is known to be important for
protein stability and some aspects of membrane physiol-
ogy, such as transporter trafficking and modulation. The
atomic structure of LeuTAa is also consistent with the idea
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because, although it forms a dimer in the crystal, each
monomer has independent binding sites defined by trans-
membrane helices provided by the single monomer. In
contrast, dominance effects have been observed in DAT
[47] and SERT coexpression experiments [43], thus sug-
gesting that oligomerization plays a functional role in such
transporters. Furthermore, Seidel et al. [48] have demon-
strated that the efflux and influx of organic substrates oc-
cur through distinct moieties within an oligomeric neuro-
transmitter transporter.
Mutants of the Q291 residue lack all transport activity,
including the so-called pre-steady-state current that rep-
resents a partial and initial step in the transport cycle
(figs. 2A, 3). This current is quantitatively related to the
current coupled to the GABA transport and is believed to
be strictly linked to the interaction of sodium with the
transporter [41, 49]. As most of the proposed mechanis-
tic models explaining the operational mode of GAT-1 as-
sume that the first event is sodium binding [4, 22, 24, 38,
49], probably followed by conformational transitions
that allow GABA recognition and transport, we specu-
lated that the Q291 mutants may be unable to start the
transport cycle because of their inability to recognize or
bind sodium. It is worth noting that, defective GABA
recognition cannot explain some of the experimental
data, such as the lack of transient and leak currents in the
Q291 mutants.
Given that none of the mutants were functional (including
C74A/Q291C), we attempted to clarify the role of Q291
further by investigating the accessibility of some adjacent
residues from the external milieu. The strong inhibition
exerted by the impermeant MTS reagents on C74A/
T290C and C74A/S295C (figs. 5, 6) suggests that the
cysteine residues introduced into these mutants (respec-
tively before and one helix turn below Q291) face the ex-
ternal aqueous environment or a water-filled cavity com-
municating with the external milieu. 
These data are in agreement with the structure of the bac-
terial homologue solved by Yamashita et al. [26]. The
residues corresponding to GAT Q291 and the other
amino acids replaced by cysteine in the present study
(figs. 1A, C) are located in the LeuTAa in the external half
of TMD 6 (called TM6a by Yamashita et al. [26]) or in the
central, non-helical portion of TMD 6: in particular, the
GAT positions that partially tolerate cysteine substitution
(GAT-1 residues T290 and S295; fig. 5), correspond to
G249 and T254 of LeuTAa. In the conformation of LeuTAa
reported by Yamashita et al. [26], G249 is located one he-
lix turn above the leucine- and Na1 binding sites, and is
likely to face the hydrophilic pathway leading to the bind-
ing sites, which would be in line with the external acces-
sibility of the corresponding GAT T290 (fig. 6). LeuTAa
T254 is involved in the binding of both leucine and
sodium, which is consistent with the fact that the corre-
sponding GAT S295 is accessible from the external mi-
lieu (fig. 6). LeuTAa F253 (corresponding to GAT F294,
which does not tolerate cysteine replacement; fig. 5), is
involved in the binding of leucine and is ultimately con-
nected to Na+ via a hydrogen bond network.
As shown in figures 6, 7 and 8, the sulfhydryl modifica-
tion of GAT C74A/T290C, with its bulk and its charge, af-
fected both transport-associated and pre-steady-state cur-
rents, and greatly impaired the transport of [3H]GABA. It
has to be noted that, apart from its reduced activity, the un-
treated double-mutated transporter behaved like the WT
(fig. 8) but, after incubation with MTSET, its affinity for
sodium was increased and the GABA-induced currents
could no longer be seen. The positive shift observed in the
Q/V curve (fig. 8E) after MTSET treatment is an indica-
tion of the greater apparent affinity of the transporter for
sodium ions. The transporter seems to be locked in a par-
ticular step of the transport cycle (probably in the out-
ward-facing conformation), an effect that is reminiscent
of the W68L GAT-1 mutant studied by Mager et al. [22].
Obviously, in our case, the transporter cannot complete
the cycle, and so we were unable to see transport-associ-
ated currents even in the presence of 3 mM GABA (figs.
7B, 8A), possibly because the steric hindrance and charge
introduced by the MTSET modification does not allow the
completion of the transport cycle, for example by prevent-
ing GABA binding or translocation. This hypothesis is
supported by the structure reported by Yamashita et al.
[26], which shows residue G249 (T290 in GAT) close to
the leucine-binding site, and so the sulfhydryl modifica-
tion of a cysteine introduced in this position may hamper
the leucine binding.
The change in the behavior of C74A/T290C is consistent
with the involvement of this residue in cation recognition
or binding, as is also suggested by the increase in the un-
coupled or leakage current after incubation with MTSET
at a wide range of voltages (fig. 9).
The data presented in this work are compatible with the
involvement of GAT Q291 in direct interaction with the
cations and/or in maintaining the structural and func-
tional integrity of an external region of the protein that
makes it accessible to cations. The size of this water-
filled cavity, which should be at least 6 Å wide, makes it
too large to be a cation-binding site, regardless of whether
the cation is hydrated or not, because the calculated mol-
ecular dimensions of MTSET and MTSES are respec-
tively 11.5¥6.0 Å and 12.0¥6.0 Å [50]. However, as in
LeuTAa [51], GAT 290 and 295 could face a larger than
expected water-accessible cavity that harbors the driving
ion together with the driven GABA molecule. 
Alternatively, as the correct positioning of the coordinat-
ing atoms is fundamental, Q291 may contribute to a hy-
drogen bond network that stabilizes various residues on
the external surface of the transporter. This kind of struc-
ture could keep the transporter in an open conformation
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tion of Q291 could make the transporter inaccessible to
cations. However, whether the role of Q291 is to bind or
direct the cations to inner domains of the protein, it is
clear that it also involves other residues. We tested the
possibility of a polar interaction between the highly con-
served R69 of the extracellular half of TMD 1 [16] and
Q291 but, unfortunately, the mutants R69Q/Q291R and
R69L/Q291L did not show any recovery of activity in
terms of GABA uptake or currents (data not shown).
The crystal structure of LeuTAa solved by Gouaux’s group
represents a particular conformation during the transport
cycle, when the binding pocket is occluded and the exter-
nal and internal gates are closed. In this structure, Q250
(which corresponds to GAT Q291) is a key interacting
residue at the extracellular gate of the transporter, and ef-
fectively part of a hydrogen bond network that ultimately
connects Q250 to the sodium ion. Moreover, R30 (which
corresponds to GAT R69) takes part in this same hydrogen
bond network and interacts with Q250. Both the R30 and
Q250 residues interact with other key residues on top of the
binding pocket. In particular, R30 forms a water-mediated
salt link with D404 of TMD 10. This explains why the GAT
mutants R69Q/Q291R and R69L/Q291L do not recover
any activity although the residues R69 and Q291 are prob-
ably spatially close and directly interact as in LeuTAa.
This crystal structure confirms that GAT Q291 is funda-
mental to maintaining the conformational integrity of an
external region of the transporter that makes it accessible
to the substrates, and we can speculate that it may even di-
rectly interact with the cations as the substrates move to
the binding pocket. Other structures representing differ-
ent transporter conformations will probably clear up this
question. However, as Q291 is strictly conserved through-
out the Na+/Cl–-dependent neurotransmitter transporter
family, it is likely to play similar or related roles in all of
these proteins.
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